ArticleRegenerative therapy2022

Prognostic factors affecting periodontal regenerative therapy using recombinant human fibroblast growth factor-2: A 3-year cohort study.

Risako Mikami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.